Call Us Now

(916) 520-6639

Cobalt Chromium Toxicity

Mom Says Zofran Caused Daughter’s Heart Defect

On March 17th, a segment reported on a North Dakota woman treated with Zofran, the antiemetic, during her pregnancy. In an interview, Kylee Riesen discussed taking Zofran almost daily during the early months of her pregnancy to control her nausea and vomiting. She suspects Zofran (Ondansetron) caused her now 2-year-old daughter’s congenital heart defect (CHD). Her daugther, Arianah, will undergo open heart surgery in May to fix the holes in her abnormally enlarged heart.

In 2014, Dr. Gideon Koren of the The Motherisk Program of Toronto, Canada released a study detailing fetal safety concerns regarding Zofran. The study showed a “2-fold increased risk of cardiac malformations with ondansetron (Zofran), leading to an overall 30 percent increased risk of major congenital malformations.” The article also indicates how Zofran was never tested on pregnant women, and mentions that recent studies suggest the drug places the developing fetus at increased risk for birth defects.

This is only the latest of several reports raising awareness about the link between Zofran and significant birth defects. Our attorneys receive numerous inquiries from families with similar concerns. We continually follow developments regarding Zofran and it’s association with birth defects as part of our firm’s ongoing investigation into this matter. Our attorneys have decades of experience representing victims of dangerous drugs and defective medical devices. We currently evaluate potential Zofran cases on behalf of families whose child was allegedly born with a birth defect secondary to in utero exposure to this drug.

You can follow Arianah’s Heart Journey on Facebook:

Comments Off on Mom Says Zofran Caused Daughter’s Heart Defect

Comments are closed.

Web Statistics